PASQUINEL GLENN: Open Payments
NPI 1912925603 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,129 in 51 payments from 14 companies in 2025. Trend: 2023 $1,222 · 2024 $961 · 2025 $1,129
Food & beverage: $1,129
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 17 | $326 |
| Regeneron Healthcare Solutions, Inc. | 3 | $90 |
| Viatris Specialty LLC | 4 | $89 |
| Merck Sharp & Dohme LLC | 4 | $89 |
| Insmed, Inc. | 5 | $85 |
| JAZZ PHARMACEUTICALS INC. | 3 | $81 |
| Grifols USA, LLC | 3 | $76 |
| AstraZeneca Pharmaceuticals LP | 3 | $66 |
| Inspire Medical Systems, Inc. | 2 | $52 |
| Philips North America LLC | 2 | $52 |
Products named: TRELEGY ELLIPTA, NUCALA, DUPIXENT, YUPELRI, ZERBAXA, Arikayce, XYWAV, Prolastin-C Liquid.
Industry payments across TX — which companies pay providers there.
